Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
July-2017 Volume 38 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2017 Volume 38 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia

  • Authors:
    • Wei Xiang
    • Fengjing Guo
    • Weiting Cheng
    • Jiaming Zhang
    • Junming Huang
    • Rui Wang
    • Zhongxi Ma
    • Kai Xu
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Oncology, Wuhan Integrated Traditional Chinese Medicine and Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Orthopedics, Pu Ai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
  • Pages: 229-236
    |
    Published online on: June 2, 2017
       https://doi.org/10.3892/or.2017.5694
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chondrosarcoma is a bone tumor characterized by the secretion of a cartilage-like extracellular matrix. It has been proved to lack extracellular sensor primary cilia. This study aimed to illustrate a feasible therapeutic method for chondrosarcoma by regulating primary cilia assembly through inhibiting histone deacetylases 6 (HDAC6) activation. In order to detect the interaction between primary cilia and HDAC6 in human chondrosarcoma, Tubastatin A and small interfering RNA (siRNA) were used to inhibit the endogenous expression of HDAC6. Cell viability test and Transwell assay were applied to evaluate the effects of malignant biological properties. Primary cilia staining and related proteins were detected. The abnormal expression of HDAC6 and cilia intraflagellar transport protein 88 (IFT88) was found in chondrosarcoma tissues. The inhibition of HDAC6 could downregulate the proliferation of chondrosarcoma cells in a concentration- and time-dependent manner and suppress the invasion capacity of tumor cells. Besides, the downregulation of HDAC6 exhibited a negative effect on the proliferation of relevant proteins but a positive effect on the primary cilia-related expression of IFT88 and acetylated α-tubulin. Primary cilia restoration could be observed after HDAC6 siRNA transfection. The Aurora A-HDAC6 cascade was involved in regulating primary cilia resorption by affecting α-tubulin deacetylation and Tubastatin A could inhibit chondrosarcoma cell growth in vivo. These results indicate that restricting HDAC6 can restore primary cilia assembly accompanied with suppressed chondrosarcoma cell proliferation and invasion capacities. Thus, promoting primary cilia restoration by targeting HDAC6 may be a feasible potential therapeutic method for chondro­sarcoma treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Leddy LR and Holmes RE: Chondrosarcoma of bone. Cancer Treat Res. 162:117–130. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Leucht P, Monica SD, Temiyasathit S, Lenton K, Manu A, Longaker MT, Jacobs CR, Spilker RL, Guo H, Brunski JB, et al: Primary cilia act as mechanosensors during bone healing around an implant. Med Eng Phys. 35:392–402. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Muhammad H, Rais Y, Miosge N and Ornan EM: The primary cilium as a dual sensor of mechanochemical signals in chondrocytes. Cell Mol Life Sci. 69:2101–2107. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Zimmerman K and Yoder BK: SnapShot: Sensing and signaling by cilia. Cell. 161:692–2.e1. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Seeger-Nukpezah T, Little JL, Serzhanova V and Golemis EA: Cilia and cilia-associated proteins in cancer. Drug Discov Today Dis Mech. 10:e135–e142. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Hassounah NB, Bunch TA and McDermott KM: Molecular pathways: The role of primary cilia in cancer progression and therapeutics with a focus on Hedgehog signaling. Clin Cancer Res. 18:2429–2435. 2012. View Article : Google Scholar : PubMed/NCBI

7 

de Andrea CE, Zhu JF, Jin H, Bovée JV and Jones KB: Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency. J Pathol. 236:210–218. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Izawa I, Goto H, Kasahara K and Inagaki M: Current topics of functional links between primary cilia and cell cycle. Cilia. 4:122015. View Article : Google Scholar : PubMed/NCBI

9 

Ke YN and Yang WX: Primary cilium: An elaborate structure that blocks cell division? Gene. 547:175–185. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Yu F, Ran J and Zhou J: Ciliopathies: Does HDAC6 represent a new therapeutic target? Trends Pharmacol Sci. 37:114–119. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Ran J, Yang Y, Li D, Liu M and Zhou J: Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly. Sci Rep. 5:129172015. View Article : Google Scholar : PubMed/NCBI

12 

Valenzuela-Fernández A, Cabrero JR, Serrador JM and Sánchez-Madrid F: HDAC6: A key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 18:291–297. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S and Iwase H: HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res. 10:6962–6968. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Gradilone SA, Radtke BN, Bogert PS, Huang BQ, Gajdos GB and LaRusso NF: HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Res. 73:2259–2270. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Dhanyamraju PK, Holz PS, Finkernagel F, Fendrich V and Lauth M: Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway. Mol Cancer Ther. 14:727–739. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Butler KV, Kalin J, Brochier C, Vistoli G, Langley B and Kozikowski AP: Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, Tubastatin A. J Am Chem Soc. 132:10842–10846. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Ho L, Ali SA, Al-Jazrawe M, Kandel R, Wunder JS and Alman BA: Primary cilia attenuate hedgehog signalling in neoplastic chondrocytes. Oncogene. 32:5388–5396. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Kawasaki M, Ezura Y, Hayata T, Notomi T, Izu Y and Noda M: TGF-β suppresses Ift88 expression in chondrocytic ATDC5 Cells. J Cell Physiol. 230:2788–2795. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Pugacheva EN, Jablonski SA, Hartman TR, Henske EP and Golemis EA: HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell. 129:1351–1363. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Deren ME, Yang X, Guan Y and Chen Q: Biological and chemical removal of primary cilia affects mechanical activation of chondrogenesis markers in chondroprogenitors and hypertrophic chondrocytes. Int J Mol Sci. 17:1882016. View Article : Google Scholar : PubMed/NCBI

21 

Poole CA, Jensen CG, Snyder JA, Gray CG, Hermanutz VL and Wheatley DN: Confocal analysis of primary cilia structure and colocalization with the Golgi apparatus in chondrocytes and aortic smooth muscle cells. Cell Biol Int. 21:483–494. 1997. View Article : Google Scholar : PubMed/NCBI

22 

Song B, Haycraft CJ, Seo HS, Yoder BK and Serra R: Development of the post-natal growth plate requires intraflagellar transport proteins. Dev Biol. 305:202–216. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Yuan X and Yang S: Primary cilia and intraflagellar transport proteins in bone and cartilage. J Dent Res. 95:1341–1349. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Xiang W, Jiang T, Guo F, Xu T, Gong C, Cheng P, Zhao L, Cheng W and Xu K: Evaluating the role of PTH in promotion of chondrosarcoma cell proliferation and invasion by inhibiting primary cilia expression. Int J Mol Sci. 15:19816–19831. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Mahankali M, Henkels KM, Speranza F and Gomez-Cambronero J: A non-mitotic role for Aurora kinase A as a direct activator of cell migration upon interaction with PLD, FAK and Src. J Cell Sci. 128:516–526. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Al-Bataineh MM, Alzamora R, Ohmi K, Ho PY, Marciszyn AL, Gong F, Li H, Hallows KR and Pastor-Soler NM: Aurora kinase A activates the vacuolar H+-ATPase (V-ATPase) in kidney carcinoma cells. Am J Physiol Renal Physiol. 310:F1216–F1228. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Kozyreva VK, McLaughlin SL, Livengood RH, Calkins RA, Kelley LC, Rajulapati A, Ice RJ, Smolkin MB, Weed SA and Pugacheva EN: NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner. Mol Cancer Res. 12:681–693. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xiang W, Guo F, Cheng W, Zhang J, Huang J, Wang R, Ma Z and Xu K: HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia. Oncol Rep 38: 229-236, 2017.
APA
Xiang, W., Guo, F., Cheng, W., Zhang, J., Huang, J., Wang, R. ... Xu, K. (2017). HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia. Oncology Reports, 38, 229-236. https://doi.org/10.3892/or.2017.5694
MLA
Xiang, W., Guo, F., Cheng, W., Zhang, J., Huang, J., Wang, R., Ma, Z., Xu, K."HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia". Oncology Reports 38.1 (2017): 229-236.
Chicago
Xiang, W., Guo, F., Cheng, W., Zhang, J., Huang, J., Wang, R., Ma, Z., Xu, K."HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia". Oncology Reports 38, no. 1 (2017): 229-236. https://doi.org/10.3892/or.2017.5694
Copy and paste a formatted citation
x
Spandidos Publications style
Xiang W, Guo F, Cheng W, Zhang J, Huang J, Wang R, Ma Z and Xu K: HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia. Oncol Rep 38: 229-236, 2017.
APA
Xiang, W., Guo, F., Cheng, W., Zhang, J., Huang, J., Wang, R. ... Xu, K. (2017). HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia. Oncology Reports, 38, 229-236. https://doi.org/10.3892/or.2017.5694
MLA
Xiang, W., Guo, F., Cheng, W., Zhang, J., Huang, J., Wang, R., Ma, Z., Xu, K."HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia". Oncology Reports 38.1 (2017): 229-236.
Chicago
Xiang, W., Guo, F., Cheng, W., Zhang, J., Huang, J., Wang, R., Ma, Z., Xu, K."HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia". Oncology Reports 38, no. 1 (2017): 229-236. https://doi.org/10.3892/or.2017.5694
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team